Compound ID | 2456
Class: Beta-lactam
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Activation of prodrug by beta-lactamases |
| Target Pathogen: | Active against Escherichia coli expressing ESBLs |
| Description: | Synthetic compound; restricts activity of ciprofloxacin to bacteria expressing beta-lactamases; a beta-lactam/fluoroquinolone prodrug |
| Institute where first reported: | MRC Centre for Molecular Bacteriology and Infection, Imperial College London, SW7 2AZ London, United Kingdom |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/146613145 |
| Citation: | https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01923 |
| Patent: | WO2020099858A1 |